Samsung-funded precision medicine platform covers over 60% of Korea's pediatric solid tumor patients

Coverage, in order

1. 2d ago
   Korea Biomedical Review South Korea obscure n=60

   Samsung-funded precision medicine platform covers over 60% of Korea's pediatric solid tumor patients

   More than 60 percent of children with solid tumors in Korea are now included in a nationwide precision medicine platform backed by a 300 billion won ($200 million) donation from the family of the late Samsung Chairman Lee Kun-hee, according to Seoul National University Hospital (SNUH).The hospital s

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.